ALDH7A1 and tuberous sclerosis: Examples of currently utilized personalized medicine techniques based on genetic information include, as examples, the use of mTOR inhibitors in patients with TSC or supplementation of pyridoxine in the context of ALDH7A1 pathogenic variants [122,125].